ARCHIVES

ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard

This article is from The Cancer Letter archive.

Vol. 28 No. 33 | September 13, 2002

Download PDF Visit The Full Archive

Related Articles

Duke Promised $11.5M For Eye, Lung Research.

March 8, 2002

Coalition Demands Role In Deciding spending will Target Healy, Broder, Chabner

October 16, 1992

SWOG Study To Test Predictive Value Of Circulating Tumor Cells In Breast Cancer

October 27, 2006

New P01 Guidelines Will Go Into Effect Feb. 1 Not Oct. 1

September 16, 1983

GAO Criticizes Distribution Of Comprehensive Cancer Centers, Cite Needs for “Focal Point” Clarification

March 26, 1976

Journal Editors Were Unaware Of Tobacco Funding.

March 28, 2008